Search

Search Constraints

You searched for: Record Type Journal Article Author/Creator Geoerger, Birgit

Search Results

11. Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma. Issue 1 (7th July 2021)

12. Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma. Issue 1 (21st September 2021)

13. CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS. (12th November 2021)

14. CTNI-62. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS. (14th November 2022)

15. CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET. (9th November 2020)

16. DIPG-61. RESCUE REGIMENS AFTER BIOMEDE: POSSIBLE INFLUENCE ON OS ASSESSMENT. (4th December 2020)

17. Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors. Issue 6 (27th November 2021)

18. Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600–Mutant Low-Grade Glioma. Issue 3 (14th November 2022)

19. Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma. Issue 4 (28th November 2017)

20. EPCT-08. ACTIVITY OF LAROTRECTINIB IN PEDIATRIC TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS. (4th December 2020)